This menu provides the list of EV miRNAs identified by high-throughput analyses.

Search:
Superdomain: All Prokaryote Eukaryote
Filter datasets:
  - "Sample type" indicates the source from which EVs originated (e.g. B cell, serum).
  - "Sample status" indicates the condition of the source from which EVs originated (e.g. Normal, miR-146a-treated, Patients of hernia).
Maximum false positive rate (FPR): Maximum true positive rate (TPR):
  - FPR is the probability that an absent miRNA accidently have higher intensity than that miRNA.
  - TPR is the percentile of miRNA among the present miRNAs.
    Please see user manual in the contact us/help menu for detail.
Number of molecules in one page:

The downloaded CSV file is not exactly the same as the displayed table. Opening CSV file with Excel can impair its content.

Since there are multiple primers in the microarray, the same miRNA can have several FPR and TPR values.

Mature name miRBase accession FPR TPR Publication Orthologous group Identification count
All / Prokaryote / Eukaryote
(FPR<0.05,TPR<0.5)
hsa-miR-365a-5pMIMAT0009199 0.0e+0 3.6e-1Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.
Sci Signal. 2014 Jul 1;7(332):ra63. doi: 10.1126/scisignal.2005231.		MIPF0000061_114 / 0 / 14
hsa-miR-365a-5pMIMAT0009199 1.1e-5 4.7e-1Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.		MIPF0000061_114 / 0 / 14
hsa-miR-365a-5pMIMAT0009199 2.9e-4 4.5e-1Extracellular vesicle miR-7977 is involved in hematopoietic dysfunction of mesenchymal stromal cells via poly(rC) binding protein 1 reduction in myeloid neoplasms.
Haematologica. 2016 Jan 22. pii: haematol.2015.134932.		MIPF0000061_114 / 0 / 14
bta-miR-365-3pMIMAT0004341 0.0e+0 1.8e-1Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes.
PLoS One. 2016 Sep 9;11(9):e0162496. doi: 10.1371/journal.pone.0162496. eCollection 2016.		MIPF0000061_114 / 0 / 14
cfa-miR-365MIMAT0001540 1.4e-15 1.4e-15Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000061_114 / 0 / 14
ptr-miR-365MIMAT0008117 1.4e-15 1.4e-15Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
J Clin Invest. 2017 Apr 3;127(4):1375-1391. doi: 10.1172/JCI87993. Epub 2017 Mar 20.		MIPF0000061_114 / 0 / 14
hsa-miR-365b-5pMIMAT0022833 0.0e+0 4.9e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000061_114 / 0 / 14
hsa-miR-365a-5pMIMAT0009199 0.0e+0 4.6e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000061_114 / 0 / 14
hsa-miR-365b-5pMIMAT0022833 0.0e+0 4.4e-1Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner.
Int J Nanomedicine. 2017 May 15;12:3721-3733. doi: 10.2147/IJN.S131516. eCollection 2017.		MIPF0000061_114 / 0 / 14
mmu-miR-365-2-5pMIMAT0017179 0.0e+0 5.5e-9Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000061_114 / 0 / 14
mmu-miR-365-1-5pMIMAT0017077 0.0e+0 1.4e-1Exosomes derived from pancreatic cancer cells induce insulin resistance in C2C12 myotube cells through the PI3K/Akt/FoxO1 pathway.
Sci Rep. 2017 Jul 14;7(1):5384. doi: 10.1038/s41598-017-05541-4.		MIPF0000061_114 / 0 / 14
hsa-miR-365b-5pMIMAT0022833 0.0e+0 4.1e-1Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.
Am J Cancer Res. 2017 Sep 1;7(9):1913-1925. eCollection 2017.		MIPF0000061_114 / 0 / 14
hsa-miR-365b-5pMIMAT0022833 0.0e+0 2.9e-1Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000061_114 / 0 / 14
hsa-miR-365a-5pMIMAT0009199 0.0e+0 1.8e-1Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000061_114 / 0 / 14
hsa-miR-365b-5pMIMAT0022833 0.0e+0 1.8e-1Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000061_114 / 0 / 14
hsa-miR-365b-5pMIMAT0022833 7.8e-3 7.8e-3Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000061_114 / 0 / 14
hsa-miR-365b-5pMIMAT0022833 1.7e-2 1.7e-2Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000061_114 / 0 / 14
hsa-miR-365a-5pMIMAT0009199 2.9e-2 2.9e-2Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer.
Nat Commun. 2018 Jan 15;9(1):191. doi: 10.1038/s41467-017-02583-0.		MIPF0000061_114 / 0 / 14
[1]